Publikace
- Development of submicromolar 17 beta-HSD10 inhibitors and their in vitro and in vivo evaluation2023 | 1. lékařská fakulta
- Novel D-2/5-HT receptor modulators related to cariprazine with potential implication to schizophrenia treatment2022 | Ústřední knihovna
- Phenothiazine-Tacrine Heterodimers: Pursuing Multitarget Directed Approach in Alzheimer's Disease2021 | Publikace bez příslušnosti k fakultě
- Development of versatile and potent monoquaternary reactivators of acetylcholinesterase2021 | Publikace bez příslušnosti k fakultě
- From orexin receptor agonist YNT-185 to novel antagonists with drug-like properties for the treatment of insomnia2020 | Publikace bez příslušnosti k fakultě
- Combination of Memantine and 6-Chlorotacrine as Novel Multi-Target Compound against Alzheimer's Disease2019 | Publikace bez příslušnosti k fakultě
- New dual small molecules for Alzheimer's disease therapy combining histamine H-3 receptor (H3R) antagonism and calcium channels blockade with additional Cholinesterase inhibition2019 | Publikace bez příslušnosti k fakultě
- Investigation of new orexin 2 receptor modulators using in silico and in vitro methods2018 | Publikace bez příslušnosti k fakultě
- Differentiated SH-SY5Y neuroblastoma cells as a model for evaluation of nerve agent-associated neurotoxicity2023 | Farmaceutická fakulta v Hradci Králové, 1. lékařská fakulta
- Tacrine First-Phase Biotransformation and Associated Hepatotoxicity: A Possible Way to Avoid Quinone Methide Formation2023 | Farmaceutická fakulta v Hradci Králové
Loading network view...